安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Atrial Fibrillation Early Recurrence After Cardioversion - Medscape
Electrical cardioversion (ECV) of persistent atrial fibrillation (AF) to normal sinus rhythm (NSR) is an accepted strategy of therapy However, this procedure presents the drawback of the
- Electrical Cardioversion for AF -- The State of the Art - Medscape
Complications of cardioversion are fortunately very rare particularly if care is taken as to technique and pre-procedural preparation Potential complications relate to the general anesthetic, the
- Electrical Cardioversion for AF -- The State of the Art - Page 2 - Medscape
Improving Immediate Cardioversion Success Aside from patient factors, a number of factors may influence the immediate success of cardioversion, that is, a complete failure to cardiovert These
- Into the Fray: Cardioversion Without OAC in Watchman Patients - Medscape
At the time of cardioversion, 34% of patients were on oral anticoagulation, 30% dual antiplatelet therapy (aspirin 81 mg daily and clopidogrel 75 mg daily), and 36% on aspirin 81 mg Immediately
- How Long Should Patients Be Monitored Following Outpatient Cardioversion?
Outpatient cardioversion of atrial arrhythmias is a low-risk, effective, and economical procedure [] In a retrospective analysis of outpatient cardioversion of 532 consecutive patients performed
- RACE 7 ACWAS: Delayed Cardioversion Effective for Recent . . . - Medscape
Delaying cardioversion is as safe and effective as acute cardioversion for recent-onset atrial fibrillation, a randomized trial shows Many cases revert to sinus rhythm without cardioversion
- Electrical Cardioversion for AF -- The State of the Art - Page 3 - Medscape
Introduction Improving Immediate Cardioversion Success Maintenance of Sinus Rhythm Following Cardioversion Future Developments Research References Maintenance of Sinus Rhythm Following
- Better Late Than Never. SHAM-PVI Shows That AF Ablation Works - Medscape
Electrophysiologist John Mandrola interviews Rick Veasey and Rajdip Dulai about the strengths and limits of the SHAM-PVI study, the first sham-controlled trial of atrial fibrillation ablation
|
|
|